Q.01

Which biocidal uses of DDAC are allowed in Great Britain?

DDAC (CAS 7173-51-5) is fully approved in Great Britain for one use only: wood preservatives (PT08). That approval ran from 1 February 2015, expires 31 July 2031 and is under renewal [1]. HSE lists eight more product types as "Under review" in the review programme, and every other product type as "Not approved".

Status of DDAC (EC 230-525-2) by product type on the HSE GB list

Product typeGB statusMarket end date
PT08 Wood preservativesApproved, under renewal (expires 31 July 2031) [1]n/a
PT01 Human hygieneUnder review [2]n/a
PT02 Disinfectants and algaecides (not for direct use on humans or animals)Under review [3]n/a
PT03 Veterinary hygieneUnder review [4]n/a
PT04 Food and feed areaUnder review [5]n/a
PT06 In-can (storage) preservativesUnder review [6]n/a
PT10 Construction material preservativesUnder review [7]n/a
PT11 Liquid-cooling and processing system preservativesUnder review [8]n/a
PT12 SlimicidesUnder review [9]n/a
PT07 Film preservativesNot approved [10]9 Feb 2011
PT09 Fibre, leather, rubber and polymer preservativesNot approved [11]9 Feb 2011
PT13 Working or cutting fluid preservativesNot approved [12]25 Oct 2009
PT16 Molluscicides and vermicidesNot approved [13]3 Jan 2008
PT18 Insecticides and acaricidesNot approved [14]3 Jan 2008

HSE marks DDAC "Can be used in treated articles: Yes" for PT08 and for all eight PTs under review. It marks "No" for the not-approved PTs.

GB Article 95 supplier list: the active section names DDAC suppliers for the nine PTs that are approved or under review: PT01 [15], PT02 [16], PT03 [17], PT04 [18], PT06 [19], PT08 [20], PT10 [21], PT11 [22] and PT12 [23]. I didn't open the GB transitional provisions that set the market rules for PTs still under review, so I'm not stating those rules here.

GB-authorised products containing DDAC: all six are PT08 wood preservatives, and each also contains DDACarbonate and basic copper carbonate.

  • Celcure M65, GB-2018-1132: Current, runs to 21 June 2028 [24]
  • Celcure C65, GB-2018-1157: Current, runs to 29 October 2028 [25]
  • Tanalith E 8000, 8001, 8002 and 8003 (GB-2018-1129 and its -0001 to -0003 numbers): Current, under renewal, run to 3 June 2028 [26][27][28][29]

Related substances listed separately:

  • DDAC (C8-10), CAS 68424-95-3: under review for PT02, PT03, PT04 and PT12. It is not approved for PT01, PT06, PT10 and PT11, which had a market end date of 2 February 2025 [30]. It is also not approved for PT08 [31].
  • DDAB (the bromide): not approved in any PT; its market end date was 28 November 2017 [32].

Approach: I searched the HSE GB BPR active substances list, the GB Article 95 supplier list and the GB register of authorised biocidal products. The PT08 approval conditions themselves are not in these records.

Q.02

How do the EU rules differ?

The main difference is that the EU has approved DDAC (CAS 7173-51-5) for five product types, while GB has approved it for only one. In the EU it is approved for PT01, PT02, PT03 and PT04 disinfectants as well as PT08 wood preservatives. In GB, PT08 is the only approval and PT01 to PT04 are still under review. The PT08 expiry dates also differ: the ECHA list gives 31 July 2027 for the EU, and the HSE list gives 31 July 2031 for GB.

DDAC (EC 230-525-2), EU compared with GB, by product type

PTEU status (ECHA BPR list)GB status (from the previous answer)
PT01 Human hygieneApproved 1 Feb 2024 to 31 Jan 2034, Implementing Regulation (EU) 2022/1991; not a candidate for substitution [33]Under review
PT02 Disinfectants and algaecidesApproved 1 Feb 2024 to 31 Jan 2034, Reg. (EU) 2022/1991 [34]Under review
PT03 Veterinary hygieneApproved 1 Nov 2022 to 31 Oct 2032, Reg. (EU) 2021/1045 [35]Under review
PT04 Food and feed areaApproved 1 Nov 2022 to 31 Oct 2032, Reg. (EU) 2021/1045 [36]Under review
PT08 Wood preservativesApproved from 1 Feb 2015, expires 31 Jul 2027, renewal in progress; approval act listed as Implementing Decision (EU) 2024/2411; candidate for substitution "Under assessment" [37]Approved, expires 31 Jul 2031, under renewal
PT06, PT10, PT11, PT12Initial approval application in progress, with Italy as evaluating authority [38][39][40][41]Under review

The ECHA list has DDAC entries for only these nine product types. It has none for PT07, PT09, PT13, PT16 or PT18, which HSE lists as "Not approved" with market end dates.

EU Article 95 list: DDAC suppliers are listed for the same nine PTs that GB covers: PT01 [42], PT02 [43], PT03 [44], PT04 [45], PT06 [46], PT08 [47], PT10 [48], PT11 [49] and PT12 [50].

EU-authorised products containing DDAC: nine national authorisations. GB has six products, all PT08 wood preservatives.

  • PT03, one product: BE-0034816-0000 (Virocid F, Hygiagold and others), with ADBAC and glutaral. It is authorised in Belgium and Germany [51]. Despite the EU approvals for PT01, PT02 and PT04, I found no EU-authorised DDAC product in those PTs.

  • PT08, eight products:

    • Boracol 10_3Bd [52]
    • FKR/ANTISAPSTAIN [53]
    • IMPRALIT-ACQ/KDS family [54]
    • Kemwood ACQ 21 [55]
    • FROXYNOL W31/Protim E420 family [56]
    • Celcure M65 [57]
    • Celcure C65 [58]
    • Tanalith E 8000-8003 [59]

    The last three still carry UK-prefixed authorisation numbers in R4BP. They are the same product families HSE holds under separate GB-2018 numbers.

DDAC (C8-10), CAS 68424-95-3: in the EU it is under initial evaluation (Italy) for PT01, PT02, PT03, PT04, PT06, PT10, PT11 and PT12 [60][61][62][63]. GB, by contrast, has already marked PT01, PT06, PT10 and PT11 as not approved, with a market end date of 2 February 2025. For PT05 the EU entry is "No longer supported", under Decision (EU) 2018/1622 [64]. I found no EU list entry for DDAB.

Approach: I searched the ECHA list of BPR active substances, the EU Article 95 list and the R4BP register of authorised products, and compared them with the GB results from the previous answer. I did not open the approval acts, so the EU approval conditions are not covered here.

Q.03

What hazards must suppliers label for DDAC?

DDAC (CAS 7173-51-5, EC 230-525-2, Index 612-131-00-6) has the same harmonised entry in the EU and GB. Suppliers in both must label it with H302 (Acute Tox. 4) and H314 (Skin Corr. 1B), the GHS05 and GHS07 pictograms, and the signal word "Danger" [65][66]. Those two hazards are only the legal minimum. Suppliers must also classify any hazard the entry does not cover, and DDAC suppliers commonly notify eye and aquatic hazards.

The harmonised (mandatory) part

EU (CLP Annex VI, Table 3)GB (MCL list)
ClassificationAcute Tox. 4 *; Skin Corr. 1BAcute Tox. 4 *; Skin Corr. 1B
H-statements on the labelH302; H314H302 H314
Pictograms and signal wordGHS05; GHS07; DgrGHS05; GHS07; Dgr
SCLs, M-factors, ATEnone listednone listed
OriginOriginal CLP listing (CLP00), in force since 1 December 2010 [67]n/a

Three points that go beyond the table:

  1. The "*" on Acute Tox. 4 marks a minimum classification. In both regimes it applies unless the manufacturer or importer has data that lead to a more severe category; in that case the more severe category "must then be applied" [68][69]. So H302 is a floor, not a ceiling.
  2. Hazards the entry does not cover must still be classified. EU CLP Article 4(3) says the substance "shall be classified in accordance with that entry". It adds that where the substance "also falls within one or more hazard classes or differentiations ... not covered by an entry in Part 3 of Annex VI", classification under Title II "shall be carried out" for them [70]. GB CLP Article 4(3) has the same rule, with the GB MCL list in place of Annex VI [71]. The entry has no aquatic classification and no M-factor. If a supplier classifies DDAC as Aquatic Acute 1 or Chronic 1, the supplier sets the M-factor from available data [69].
  3. Only an EU-established supplier can place it on the EU market. Under EU CLP Article 4(11), a substance or mixture "shall not be placed on the market" unless a supplier established in the Union, "which shall be identified on the label", meets the CLP requirements [70]. The GB Article 4 text has no such paragraph.

What industry self-classifies on top (ECHA C&L Inventory)

  • The REACH joint submission:
    • Skin Corr. 1B H314 and Acute Tox. 4 (oral) H302, each from 363 notifiers [72][73]
    • Eye Dam. 1 H318, Aquatic Acute 1 H400, Aquatic Chronic 2 H411 and Acute Tox. 3 (oral) H301, each from 28 notifiers [74][75][76][77]
  • CLP notifications:
    • Eye Dam. 1, Aquatic Acute 1 and Aquatic Chronic 2, each from 168 notifiers [78][79][80]
    • Flam. Liq. 3 H226 and Acute Tox. 3 (oral) H301, each from 17 notifiers, which likely reflects solvent-containing grades [81][82]

These are company notifications, not binding classifications. Given the "*" rule, the Acute Tox. 3 notifications show that some suppliers hold data justifying a stricter oral category than the harmonised floor.

Pending changes: I found no record of a CLH intention or a RAC opinion for DDAC, so I see no pending revision of the harmonised entry.

Approach: I checked CLP Annex VI and the consolidated CLP text (Article 4 and Annex VI, section 1.2.1), the GB MCL list and the GB CLP text, the ECHA C&L Inventory, the CLH intentions registry and RAC opinions. This covers classification of the active substance only; biocidal product labels follow the product's own classification and its authorisation.

Q.04